Showing results (121-130 of 138) with videos related to
Sort By:
Pageof 14
Clinical Pharmacology and Therapeutics|November 1, 1983
Effects of size and frequency of oral doses of charcoal on theophylline clearanceG D Park, L Radomski, M J Goldberg, et al.Clinical Pharmacology and Therapeutics|March 1, 1984
Model for theophylline overdose treatment with oral activated charcoalL Radomski, G D Park, M J Goldberg, et al.Journal of Clinical Pharmacology|July 1, 1984
Effect of the surface area of activated charcoal on theophylline clearanceG D Park, R Spector, M J Goldberg, et al.Journal of Neuroendocrinology|March 17, 2012
The nonpeptide oxytocin receptor agonist WAY 267,464: receptor-binding profile, prosocial effects and distribution of c-Fos expression in adolescent ratsC Hicks, W Jorgensen, C Brown, et al.Clinical Pharmacology and Therapeutics|March 1, 1983
Enhancement of theophylline clearance by oral activated charcoalW G Berlinger, R Spector, M J Goldberg, et al.The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine|December 1, 1975
The Weissenbacher-Zweymuller syndrome of micrognathia and rhizomelic chondrodysplasia at birth with subsequent normal growthJ O Haller, W E Berdon, M Robinow, et al.Regulatory Peptides|January 2, 1992
Cat gastrinoma and the sequence of cat gastrinsJ Eng, B H Du, G F Johnson, et al.Neuroscience|June 14, 2011
Resilience and reduced c-Fos expression in P2X7 receptor knockout mice exposed to repeated forced swim testA A Boucher, J C Arnold, G E Hunt, et al.The Australian and New Zealand Journal of Psychiatry|August 1, 1997
Intensive nutritional counselling in bulimia nervosa: a role for supplementation with fluoxetine?P J Beumont, J D Russell, S W Touyz, et al.The Medical Journal of Australia|June 19, 1998
Clozapine treatment in Australia: a review of haematological monitoringD L Copolov, W R Bell, W J Benson, et al.Pageof 14